HPS-4 Activators
The chemical class termed HPS-4 Activators encompasses compounds that influence the functionality of HPS-4 by altering intracellular trafficking and organelle function. These activators exert their effects by targeting various pathways and cellular processes such as cation transport within the Golgi complex (Monensin), ER to Golgi transport (Brefeldin A), cAMP pathways (Forskolin), and the activity of PKC (PMA).
Each compound has a unique mechanism of action but ultimately affects the cellular context in which HPS-4 operates, enhancing or compensating its function in organelle biogenesis. These activators do not directly bind or modify HPS-4; instead, they create conditions that facilitate the protein's functional capacity. With varied targets like lysosomal acidity (Chloroquine), membrane composition (Methyl-β-cyclodextrin), and cytoskeletal dynamics (Nocodazole, Latrunculin A), the activators collectively represent a broad approach to modulating the complex cellular environment that governs HPS-4's activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin, a polyether antibiotic, disrupts Golgi function by altering cation transport. This disruption could potentially enhance the trafficking of proteins to lysosome-related organelles, thereby indirectly enhancing HPS-4 functionality. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits transport of molecules from the endoplasmic reticulum to the Golgi apparatus. This compound could influence the cellular pathways that HPS-4 is involved in by modulating protein trafficking and potentially compensating for defects in organelle biogenesis. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing levels of cAMP, which is a secondary messenger known to regulate a wide array of cellular functions, including vesicle trafficking, which is critical for the function of HPS-4. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in a multitude of cellular processes including organelle organization. PKC activation could enhance vesicle formation and trafficking, potentially increasing the functional capability of HPS-4. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may modulate signal transduction pathways, indirectly affecting intracellular trafficking and possibly influencing HPS-4 mediated processes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is a compound that can modulate various signaling pathways. Though not directly linked to HPS-4, it might influence endosomal/lysosomal trafficking, thereby having a potential effect on HPS-4-related functions. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is known to affect lysosomal acidity and might influence lysosomal trafficking and function. These changes could potentially affect the milieu in which HPS-4 operates within the cell. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Niclosamide uncouples oxidative phosphorylation, which could lead to alterations in cellular energy states, potentially affecting vesicle dynamics and indirectly influencing HPS-4 activity. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubules, altering intracellular transport and potentially modifying the cellular environment in a way that may impact HPS-4 function indirectly. | ||||||